GH — Guardant Health

Median target
$200
calls from the last 12 months
Implied return
+14.3%
median target vs. price
Coverage
25 analysts · 29 calls
updated in the last 12 months
Consensus
24/1/0+24 net
Buy / Hold / Sell

Which analysts are behind GH's consensus?

See every current rating, price target and the analysts' track records for Guardant Health — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 25 analysts with calls on GH updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

GH elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-10-16InsidersTariq MusaDirectorInsider sale116 sh @ $165.88 · planned trade$19K
2026-10-14InsidersAzar Alex M IiDirectorInsider sale69 sh @ $159.89 · planned trade$11K
2026-09-28CongressJonathan JacksonIL-IL01Purchasesince trade -1.3%, vs market +0.2%$15K–$50K
2026-09-16InsidersKrognes Steve E.DirectorInsider sale3.3K sh @ $175.42$579K
2026-09-16InsidersKrognes Steve E.DirectorInsider sale1.3K sh @ $176.34$229K
2026-09-16InsidersKrognes Steve E.DirectorInsider sale1.1K sh @ $174.46$192K
2026-09-16InsidersKrognes Steve E.DirectorInsider sale971 sh @ $177.48$172K
2026-09-16InsidersAzar Alex M IiDirectorInsider sale826 sh @ $175.00 · planned trade$145K
2026-09-16InsidersTariq MusaDirectorInsider sale116 sh @ $175.00 · planned trade$20K
2026-09-15InsidersChudova DaryaOfficerInsider sale7.7K sh @ $178.00$1.4M

More: congressional trades on GH · insider activity · executive branch · trending